Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3192936 | Annals of Allergy, Asthma & Immunology | 2009 | 6 Pages |
Abstract
Of the patients, 13.0% received repeated epinephrine doses. Patients were younger and were likely to present with wheezing, cyanosis, arrhythmias, hypotension and shock, stridor, laryngeal edema, cough, nausea, and emesis and less likely to have urticaria. A history of asthma did not predict use of repeated doses of epinephrine. Our results help identify high-risk patients who may benefit from carrying more than 1 dose of epinephrine.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Veena MBBS, Ronna L MD, PhD, M. Fernanda MD, Latha G. MD, James T.C. MD, PhD, Wyatt W. MD,